← Back to Search

Virus Therapy

Beta-glucan for Flu Vaccine Response (M-Unity Trial)

Phase 2
Waitlist Available
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have been immunized for COVID-19
Adult volunteers ≥ 50 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 42 days (day 1, day 14, day 15, and day 42)
Awards & highlights

M-Unity Trial Summary

This trial will test if a supplement can help the flu vaccine work better.

Who is the study for?
This trial is for healthy adults over 50 who plan to get the flu shot, can follow study procedures like blood draws and questionnaires, have had their COVID-19 shots, and can consent in English. It's not for those in other trials that might affect results, with severe vaccine reactions or immune system issues due to illness or treatments.Check my eligibility
What is being tested?
The trial tests if beta-glucan (a fiber from baker's yeast) affects the body's response to the flu vaccine compared to a placebo. Participants will receive either beta-glucan or a dummy pill alongside their regular influenza vaccination.See study design
What are the potential side effects?
Possible side effects may include typical responses to dietary supplements such as digestive discomfort. The flu vaccine itself may cause soreness at injection site, mild fever, or fatigue.

M-Unity Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have received the COVID-19 vaccine.
Select...
I am 50 years old or older.

M-Unity Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~42 days (day 1, day 14, day 15, and day 42)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 42 days (day 1, day 14, day 15, and day 42) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Antibody Titer
Secondary outcome measures
Cold and flu symptoms
Fever
Incidence of influenza and Covid-19
+1 more

M-Unity Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Beta-glucanExperimental Treatment2 Interventions
500 mg/day beta-glucan
Group II: PlaceboPlacebo Group2 Interventions
500 mg/day cellulose
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Influenza Vaccine
2010
Completed Phase 4
~6900

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,615 Total Patients Enrolled
Danstar Ferment AGUNKNOWN

Media Library

Influenza Vaccine (Virus Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05074303 — Phase 2
Healthy Aging Research Study Groups: Beta-glucan, Placebo
Healthy Aging Clinical Trial 2023: Influenza Vaccine Highlights & Side Effects. Trial Name: NCT05074303 — Phase 2
Influenza Vaccine (Virus Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05074303 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the Influenza Vaccine been given an okay from the FDA?

"The influenza vaccine has been evaluated by our team at Power and given a rating of 1 due to the limited data available concerning its safety and effectiveness in this phase 1 trial."

Answered by AI

Is the age limit for participation in this study above twenty years?

"To be enrolled in this medical trial, patients must fall between the ages of 50 and 100. Younger individuals are able to partake in 41 separate studies, while seniors over 65 have 117 different trials available for them."

Answered by AI

How many individuals have signed up to take part in this clinical trial?

"Affirmative. According to clinicaltrials.gov, this medical trial was posted on October 12th 2021 and recently updated September 12th 2022; 90 patients are currently being recruited from one center of care."

Answered by AI

Are there any vacant slots in this medical research for participants?

"In accordance with clinicaltrials.gov, this trial is searching for participants to take part in the experiment. The initial advertisement was published on 10th December 2021 and was last amended on 9th December 2022."

Answered by AI

What are the qualifications for enrolling in this research?

"This study is seeking 90 volunteers aged between 50 and 100 who display healthy aging. To be accepted, individuals must agree to follow the trial's procedures - including taking an influenza vaccine and ingesting a supplement given by the researchers - as well as attending scheduled blood draw appointments and completing surveys."

Answered by AI

Who else is applying?

What state do they live in?
Florida
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Beta-glucan and Immune Response to Influenza Vaccine
2022. "Beta-glucan and Immune Response to Influenza Vaccine". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05074303.
All > Influenza
~33 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top